big changes in chronic hepatitis C therapy with two new oral antivirals, Galexos (simeprevir) and Sovaldi (sofosbuvir)

You'll see big changes in chronic hepatitis C therapy with two new oral antivirals, Galexos (simeprevir) and Sovaldi (sofosbuvir).

Galexos (gah-LEX-ohs) is similar to Incivek (telaprevir) and Victrelis (boceprevir).

Galexos' advantage is that it's dosed once daily...seems to be better tolerated...and has fewer interactions than Incivek or Victrelis.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote